¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
»À¼ºÀå Àڱر⠽ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :
Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼¿¡ µû¸£¸é, »À¼ºÀå Àڱر⠼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 15¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 5.1%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºñħ½ÀÀû ¹× ÃÖ¼Òħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ²ÅÈü´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼úÀÇ ÀåÁ¡À¸·Î´Â ÀÛÀº Àý°³Ã¢, ³·Àº °¨¿° À§Çè, ºü¸¥ ȸº¹, ªÀº ÀÔ¿ø ±â°£, ÈäÅÍ °¨¼Ò, ¼ö¼ú Áß ÃâÇ÷·® °¨¼Ò µîÀÌ ÀÖ½À´Ï´Ù. µû¶ó¼ Àúħ½À ôÃß ¹× Á¤Çü¿Ü°ú ¼ö¼ú¿¡ °ñÇü¼º´Ü¹éÁú(BMP)°ú ´ÙÇ÷¼ÒÆÇ Ç÷Àå(PRP)ÀÇ »ç¿ë·üÀÌ ³ô¾Æ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿Ü»ó ¹× »ç°í »ç·Ê Áõ°¡µµ »À¼ºÀå Àڱر⠽ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ¿¹ÃøµÇ¸ç, WHO¿¡ µû¸£¸é ¸Å³â ¾à 2,000¸¸ ¸í¿¡¼ 5,000¸¸ ¸íÀÌ ±³Åë»ç°í·Î ÀÎÇØ ºÎ»óÀ» ÀÔ½À´Ï´Ù°í ÇÕ´Ï´Ù. ±³Åë»ç°í¿Í ¿Ü»óÀº °ñÀýÀÇ À¯ÇÕ Áö¿¬°ú À¯ÇÕ ½ÇÆÐ»Ó¸¸ ¾Æ´Ï¶ó ½É°¢ÇÑ Ã´Ãß ¼Õ»óÀ» ÃÊ·¡ÇÒ °¡´É¼ºÀÌ ³ôÀ¸¸ç, ÀÌ´Â »À¼ºÀå Àڱر⿡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
»À¼ºÀå Àڱر⠽ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- °ñ ¼ºÀå Àڱر⠺оߴ ȯÀÚÀÇ ºñħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä¿Í Á¦Ç° ¹ßÀüÀ¸·Î ÀÎÇØ 2023³â ½ÃÀå¿¡¼ °¡Àå Å« ¼öÀÍÀ» âÃâÇÑ ºÐ¾ß¿´½À´Ï´Ù.
- PRP ºÐ¾ß´Â »À ¹× ¿¬Á¶Á÷ Ä¡À¯¿¡ ´ëÇÑ Àαâ Áõ°¡, ¿ì¼öÇÑ ¾ÈÀü¼º ÇÁ·ÎÆÄÀÏ, Àç»ý Ä¡·á °³¹ßÀÇ À¯¸ÁÇÑ ¼º°ú °¡´É¼ºÀ¸·Î ÀÎÇØ ÃßÁ¤ ¹× ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- ¿ëµµº°·Î´Â ôÃß °íÁ¤ ¼ö¼ú ºÐ¾ß°¡ 2023³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ôÃß ¼Õ»ó, °ñÀý, ôÃß°ü ÇùÂøÁõ Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- º´¿ø ºÎ¹®Àº Àüü ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ¿Ü»ó¼º ¼Õ»ó, ±³Åë»ç°í, ôÃß ¼Õ»ó, °ñÀý·Î ÀÎÇÑ È¯ÀÚ ÀÔ¿ø °Ç¼ö Áõ°¡·Î ÀÎÇØ Á¶»ç ±â°£ µ¿¾È¿¡µµ ±× ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- ºÏ¹Ì°¡ 2023³â Àüü ½ÃÀåÀ» Áö¹èÇÑ ÁÖµÈ ÀÌÀ¯´Â ÀÌ Áö¿ª¿¡ ¿©·¯ ÁÖ¿ä ÀÇ·á±â±â ±â¾÷ÀÌ Á¸ÀçÇϰí ÀÇ·á ÀÎÇÁ¶ó°¡ °íµµ·Î ¹ß´ÞµÇ¾î Àֱ⠶§¹®ÀÔ´Ï´Ù.
- ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ »À¼ºÀå Àڱر⠽ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áß±¹, Àεµ, Àεµ³×½Ã¾Æ¸¦ Æ÷ÇÔÇÑ ¾Æ½Ã¾Æ ±¹°¡ÀÇ ±³Åë »ç°í Áõ°¡¿Í ÀÇ·á ÀÎÇÁ¶óÀÇ ¹ßÀüÀÌ ÀÌ Áö¿ªÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ¼¼°èÀÇ »À¼ºÀå Àڱر⠽ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå ¼·Ð/°èÅë Àü¸Á
- ½ÃÀå ±Ô¸ð¿Í ¼ºÀå Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ¼¼°èÀÇ »À¼ºÀå Àڱر⠽ÃÀå ºÐ¼® Åø
- PorterÀÇ Five Forces ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå ¼¼°èÀÇ »À¼ºÀå Àڱر⠽ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- »À¼ºÀå Àڱر⠽ÃÀå : Á¦Ç° º¯µ¿ ºÐ¼®, 2023³â ¹× 2030³â
- »À¼ºÀå Àڱرâ
- »ÀÇü¼º ´Ü¹éÁú(BMP)
- Ç÷¼ÒÆÇdzºÎÇ÷Àå(PRP)
Á¦5Àå ¼¼°èÀÇ »À¼ºÀå Àڱر⠽ÃÀå : ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- »À¼ºÀå Àڱر⠽ÃÀå : ¿ëµµ º¯µ¿ ºÐ¼®, 2023³â ¹× 2030³â
- ôÃß °íÁ¤ ¼ö¼ú
- »ÀÀ¯ÇÕ Áö¿¬ °ñÀý ¹× »ÀÀ¯ÇÕ ºÎÀü °ñÀý
- Á¤Çü¿Ü°ú ¿Ü»ó ¼ö¼ú
- ±âŸ
Á¦6Àå »À¼ºÀå Àڱر⠽ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®
- ºÎ¹® ´ë½Ãº¸µå
- »À¼ºÀå Àڱر⠽ÃÀå : ÃÖÁ¾ ¿ëµµº° º¯µ¿ ºÐ¼®, 2023³â ¹× 2030³â
- º´¿ø
- Á¤Çü¿Ü°ú Àü¹® Ŭ¸®´Ð
- ȨÄɾî ȯ°æ
- ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
Á¦7Àå ¼¼°èÀÇ »À¼ºÀå Àڱر⠽ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®
- »À¼ºÀå Àڱر⠽ÃÀå Á¡À¯À², Áö¿ªº°, 2023³â ¹× 2030³â
- ºÏ¹Ì
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- µ§¸¶Å©
- ½º¿þµ§
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- ÀϺ»
- Àεµ
- Çѱ¹
- È£ÁÖ
- ű¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
Á¦8Àå °æÀï ±¸µµ
- ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ÀÇ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
- ±â¾÷ ºÐ·ù
- ±â¾÷ È÷Æ®¸Ê ºÐ¼®
- ±â¾÷ °³¿ä
- Orthofix Holdings, Inc.
- Âü¿© ±â¾÷ °³¿ä
- À繫 ½ÇÀû
- Á¦Ç° º¥Ä¡¸¶Å·
- ÃÖ±Ù µ¿Çâ/Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê
- Medtronic
- Âü¿© ±â¾÷ °³¿ä
- À繫 ½ÇÀû
- Á¦Ç° º¥Ä¡¸¶Å·
- ÃÖ±Ù µ¿Çâ/Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê
- Zimmer Biomet
- Âü¿© ±â¾÷ °³¿ä
- À繫 ½ÇÀû
- Á¦Ç° º¥Ä¡¸¶Å·
- ÃÖ±Ù µ¿Çâ/Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê
- DePuy Synthes
- Âü¿© ±â¾÷ °³¿ä
- À繫 ½ÇÀû
- Á¦Ç° º¥Ä¡¸¶Å·
- ÃÖ±Ù µ¿Çâ/Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê
- Arthrex, Inc.
- Âü¿© ±â¾÷ °³¿ä
- À繫 ½ÇÀû
- Á¦Ç° º¥Ä¡¸¶Å·
- ÃÖ±Ù µ¿Çâ/Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê
- Bioventus
- Âü¿© ±â¾÷ °³¿ä
- À繫 ½ÇÀû
- Á¦Ç° º¥Ä¡¸¶Å·
- ÃÖ±Ù µ¿Çâ/Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê
- DJO Global, Inc.
- Âü¿© ±â¾÷ °³¿ä
- À繫 ½ÇÀû
- Á¦Ç° º¥Ä¡¸¶Å·
- ÃÖ±Ù µ¿Çâ/Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê
- Ossatec benelux
- Âü¿© ±â¾÷ °³¿ä
- À繫 ½ÇÀû
- Á¦Ç° º¥Ä¡¸¶Å·
- ÃÖ±Ù µ¿Çâ/Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê
- Altis biologics
- Âü¿© ±â¾÷ °³¿ä
- À繫 ½ÇÀû
- Á¦Ç° º¥Ä¡¸¶Å·
- ÃÖ±Ù µ¿Çâ/Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê
- BTT health GMBH
- Âü¿© ±â¾÷ °³¿ä
- À繫 ½ÇÀû
- Á¦Ç° º¥Ä¡¸¶Å·
- ÃÖ±Ù µ¿Çâ/Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê
- IGEA
- Âü¿© ±â¾÷ °³¿ä
- À繫 ½ÇÀû
- Á¦Ç° º¥Ä¡¸¶Å·
- Isto Biologics
- Âü¿© ±â¾÷ °³¿ä
- À繫 ½ÇÀû
- Á¦Ç° º¥Ä¡¸¶Å·
- ÃÖ±Ù µ¿Çâ/Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê
LSH 24.09.26
Bone Growth Stimulators Market Growth & Trends:
The global bone growth stimulators market size is anticipated to reach USD 1.53 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.1% from 2024 to 2030. Escalating demand for noninvasive and minimally invasive treatments is a major factor estimated to boost market growth during the forecast period. Some advantages offered by minimally invasive surgeries are smaller incisions, low risk of infections, speedy recovery, shorter stay at the hospital, reduced scarring, and minimal blood loss during surgery. Thus, there is high adoption of Bone Morphogenetic Proteins (BMP) and Platelet-rich Plasma (PRP) for minimally invasive spinal and orthopedic surgeries, which is expected to boost the market growth.
The rising number of trauma and accident cases is another major factor projected to support the growth of the bone growth stimulator market. According to WHO, around 20 to 50 million people are injured every year due to road accidents. Road accidents and trauma are likely to result in severe spinal injuries as well as delayed union or nonunion of bone fractures, which is projected to drive demand for bone growth stimulators.
Bone Growth Stimulators Market Report Highlights:
- Bone growth stimulation devices segment was the largest revenue grossing segment of the market in 2023 owing to high demand for noninvasive treatments by patients as well as product advancements.
- PRP segment is estimated to grow at the highest CAGR during the forecast period owing to its growing popularity for bone and soft tissue healing, as well as its favorable safety profile and potential promising outcome for the development of regenerative treatments.
- In the application segment, the spinal fusion surgeries segment accounted for the largest share in 2023 and is projected to maintain its dominance during the forecast period owing to the escalating number of spinal injuries, fractures, and spinal stenosis.
- The hospitals segment accounted for the largest share in the overall market and is expected to maintain its dominance during the study period due to escalating number of admissions of patients suffering from traumatic injuries, road accidents, spinal injuries, and bone fractures.
- North America dominated the overall market in 2023 mainly due to the existence of several leading medical device companies in this region and highly developed healthcare infrastructure.
- The Asia Pacific bone growth stimulator market is projected to grow at the highest rate during the forecast period. The rising number of road accidents and developing healthcare infrastructure in Asian countries, including China, India, and Indonesia, are major factors contributing to growth in this region.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Global Bone Growth Stimulators Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Billion)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Global Bone Growth Stimulators Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
Chapter 4. Global Bone Growth Stimulators Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Bone Growth Stimulators Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
- 4.3. Bone growth stimulation devices
- 4.3.1. Bone Growth Stimulation Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4. Bone Morphogenetic Proteins (BMP)
- 4.4.1. Bone Morphogenetic Proteins (BMP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.5. Platelet-Rich Plasma (PRP)
- 4.5.1. Platelet-Rich Plasma (PRP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Global Bone Growth Stimulators Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Bone Growth Stimulators Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
- 5.3. Spinal fusion surgeries
- 5.3.1. Spinal fusion surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.4. Delayed union & nonunion bone fractures
- 5.4.1. Delayed union & nonunion bone fractures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.5. Orthopedic trauma surgeries
- 5.5.1. Orthopedic trauma surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.6. Other Accessories
- 5.6.1. Other Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Globe Bone Growth Stimulators Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Bone Growth Stimulators Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
- 6.3. Hospitals
- 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4. Specialized Orthopedic Clinics
- 6.4.1. Specialized Orthopedic Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5. Home Care Settings
- 6.5.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6. Ambulatory Surgical Centers
- 6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Globe Bone Growth Stimulators Market: Regional Estimates & Trend Analysis
- 7.1. Bone Growth Stimulators Market Share, By Region, 2023 & 2030 (USD Billion)
- 7.2. North America
- 7.2.1. North America Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.2.2. U.S.
- 7.2.2.1. U.S. Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.2.3. Canada
- 7.2.3.1. Canada Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.2.4. Mexico
- 7.2.4.1. Mexico Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.3. Europe
- 7.3.1. Europe Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.3.2. U.K.
- 7.3.2.1. U.K. Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.3.3. Germany
- 7.3.3.1. Germany Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.3.4. Italy
- 7.3.4.1. Italy Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.3.5. Spain
- 7.3.5.1. Spain Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.3.6. Denmark
- 7.3.6.1. Denmark Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.3.7. Sweden
- 7.3.7.1. Sweden Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.3.8. Norway
- 7.3.8.1. Norway Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.4.2. China
- 7.4.2.1. China Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.4.3. Japan
- 7.4.3.1. Japan Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.4.4. India
- 7.4.4.1. India Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.4.5. South Korea
- 7.4.5.1. South Korea Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.4.6. Australia
- 7.4.6.1. Australia Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.4.7. Thailand
- 7.4.7.1. Thailand Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.5. Latin America
- 7.5.1. Latin America Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.5.2. Brazil
- 7.5.2.1. Brazil Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.5.3. Argentina
- 7.5.3.1. Argentina Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.6.2. Saudi Arabia
- 7.6.2.1. Saudi Arabia Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.6.3. UAE
- 7.6.3.1. UAE Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.6.4. South Africa
- 7.6.4.1. South Africa Bone Growth Stimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis by Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Heat Map Analysis
- 8.4. Company Profiles
- 8.5. Orthofix Holdings, Inc.
- 8.5.1. Participant's Overview
- 8.5.2. Financial Performance
- 8.5.3. Product Benchmarking
- 8.5.4. Recent Developments/ Strategic Initiatives
- 8.6. Medtronic
- 8.6.1. Participant's Overview
- 8.6.2. Financial Performance
- 8.6.3. Product Benchmarking
- 8.6.4. Recent Developments/ Strategic Initiatives
- 8.7. Zimmer Biomet
- 8.7.1. Participant's Overview
- 8.7.2. Financial Performance
- 8.7.3. Product Benchmarking
- 8.7.4. Recent Developments/ Strategic Initiatives
- 8.8. DePuy Synthes
- 8.8.1. Participant's Overview
- 8.8.2. Financial Performance
- 8.8.3. Product Benchmarking
- 8.8.4. Recent Developments/ Strategic Initiatives
- 8.9. Arthrex, Inc.
- 8.9.1. Participant's Overview
- 8.9.2. Financial Performance
- 8.9.3. Product Benchmarking
- 8.9.4. Recent Developments/ Strategic Initiatives
- 8.10. Bioventus
- 8.10.1. Participant's Overview
- 8.10.2. Financial Performance
- 8.10.3. Product Benchmarking
- 8.10.4. Recent Developments/ Strategic Initiatives
- 8.11. DJO Global, Inc.
- 8.11.1. Participant's Overview
- 8.11.2. Financial Performance
- 8.11.3. Product Benchmarking
- 8.11.4. Recent Developments/ Strategic Initiatives
- 8.12. Ossatec benelux
- 8.12.1. Participant's Overview
- 8.12.2. Financial Performance
- 8.12.3. Product Benchmarking
- 8.12.4. Recent Developments/ Strategic Initiatives
- 8.13. Altis biologics
- 8.13.1. Participant's Overview
- 8.13.2. Financial Performance
- 8.13.3. Product Benchmarking
- 8.13.4. Recent Developments/ Strategic Initiatives
- 8.14. BTT health GMBH
- 8.14.1. Participant's Overview
- 8.14.2. Financial Performance
- 8.14.3. Product Benchmarking
- 8.14.4. Recent Developments/ Strategic Initiatives
- 8.15. IGEA
- 8.15.1. Participant's Overview
- 8.15.2. Financial Performance
- 8.15.3. Product Benchmarking
- 8.16. Isto Biologics
- 8.16.1. Participant's Overview
- 8.16.2. Financial Performance
- 8.16.3. Product Benchmarking
- 8.16.4. Recent Developments/ Strategic Initiatives